It was also shown that 1, at a concentration of 5 μM, exhibits antiandrogenic activity in human prostate cancer cell lines (e.g., LNCaP), preventing the binding of labeled synthetic androgen R1881 (5 nM) to the androgen receptor (AR). This evidence concerns the gene AR and Familial prostate cancer.